Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer (Q35001203)

5 August 2017

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer (English)

1 reference

5 August 2017

1 reference

1 reference

4

Sabine Tejpar

0 references

author name string

Vlad Popovici

1

1 reference

5 August 2017

Eva Budinska

2

1 reference

5 August 2017

Fred T Bosman

3

1 reference

5 August 2017

Arnaud D Roth

5

1 reference

5 August 2017

Mauro Delorenzi

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

27 September 2013

1 reference

5 August 2017

1 reference

5 August 2017

13

1 reference

5 August 2017

439

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-439

5 August 2017

0 references

cites work

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Molecular origins of cancer: Molecular basis of colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Colorectal cancer and genetic alterations in the Wnt pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Genetic alterations during colorectal-tumor development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Allelotype of colorectal carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849526

Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-439

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24073892

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-13-439

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference